Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 610

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Hypertriglyceridemia, insulin resistance, and the metabolic syndrome

Grundy, Scott M·1999·The American Journal of Cardiology

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0002-9149(99)00211-8

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Research works printed but not linked: 49

  1. Grundy, 1990, Coronary heart disease in high-risk populations, Eur Heart J, 11, 462, 10.1093/oxfordjournals.eurheartj.a059730 · DOI
  2. Williams, 1992, Familial dyslipidaemic hypertension and other multiple metabolic syndromes, Ann Med, 24, 469, 10.3109/07853899209166998 · DOI
  3. Juhan-Vague, 1991, Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosis, Diabetologia, 34, 457, 10.1007/BF00403280 · DOI · Paper page
  4. Reaven, 1995, Pathophysiology of insulin resistance in human disease, Physiol Rev, 75, 473, 10.1152/physrev.1995.75.3.473 · DOI · Paper page
  5. DeFronzo, 1991, Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease, Diabetes Care, 14, 173, 10.2337/diacare.14.3.173 · DOI · Paper page
  6. Garg, 1994, Effects of varying carbohydrate content of diet in patients with noninsulin-dependent diabetes mellitus, JAMA, 271, 1421, 10.1001/jama.1994.03510420053034 · DOI · Paper page
  7. Rowe, 1983, Characterization of the insulin resistance of aging, J Clin Invest, 71, 1581, 10.1172/JCI110914 · DOI · Paper page
  8. Walker, 1996, Abnormal glucocorticoid activity in subjects with risk factors for cardiovascular disease, Endocr Res, 22, 701, 10.1080/07435809609043765 · DOI
  9. Dunaif, 1997, Insulin resistance and the polycystic ovary syndrome, Endocr Rev, 18, 774
  10. Kissebah, 1976, Role of insulin resistance in adipose tissue and liver in the pathogenesis of endogenous hypertriglyceridemia in man, Diabetologia, 12, 563, 10.1007/BF01220632 · DOI · Paper page
  11. Steiner, 1994, Hyperinsulinaemia and hypertriglyceridaemia, J Intern Med Suppl, 736, 23
  12. Mostaza, 1998, Abnormal metabolism of free fatty acids in hypertriglyceridaemic men, J Intern Med, 243, 265, 10.1046/j.1365-2796.1998.00298.x · DOI
  13. Windler, 1985, Inhibitory effects of C apolipoproteins from rats and humans on the uptake of triglyceride-rich lipoproteins and their remnants by the perfused rat liver, J Lipid Res, 26, 556, 10.1016/S0022-2275(20)34342-X · DOI · Paper page
  14. Haffner, 1995, A preponderance of small dense LDL is associated with specific insulin, proinsulin and the components of the insulin resistance syndrome in non-diabetic subjects, Diabetologia, 38, 1328, 10.1007/BF00401766 · DOI
  15. Karhapaa, 1994, Isolated low HDL cholesterol. An insulin-resistance state, Diabetes, 43, 411, 10.2337/diab.43.3.411 · DOI
  16. Edelson, 1993, Insulin resistance in hypertension, Am J Med Sci, 306, 345, 10.1097/00000441-199311000-00014 · DOI
  17. Sowers, 1990, Insulin resistance and hypertension, Mol Cell Endocrinol, 74, C87, 10.1016/0303-7207(90)90110-T · DOI
  18. Hopkins, 1996, Hypertension, dyslipidemia, and insulin resistance, Curr Opin Lipidol, 7, 241, 10.1097/00041433-199608000-00011 · DOI
  19. Williams, 1988, Familial dyslipidemic hypertension. Evidence from 58 Utah families for a syndrome present in approximately 12% of patients with essential hypertension, JAMA, 259, 3579, 10.1001/jama.1988.03720240041032 · doi:10.1001/jama.1988.03720240041032 · Paper page
  20. Eriksson, 1992, Metabolic disturbances in hypertension: results from the population study “men born in 1913.”, J Intern Med, 232, 389, 10.1111/j.1365-2796.1992.tb00604.x · DOI
  21. Miller, 1994, Lipoproteins and the haemostatic system in atherothrombotic disorders, Baillieres Clin Haematol, 7, 713, 10.1016/S0950-3536(05)80105-2 · DOI
  22. Hiraga, 1996, Hypertriglyceridemia, but not hypercholesterolemia, is associated with the alterations of fibrinolytic system, Horm Metab Res, 28, 603, 10.1055/s-2007-979862 · DOI
  23. Ohni, 1995, Serum triglycerides and blood coagulation factors VII and X, and plasminogen activator inhibitor-1, J Atheroscler Thromb, 2, S41, 10.5551/jat1994.2.Supplement1_S41 · DOI
  24. Asplund-Carlson, 1993, Relationship between plasma plasminogen activator inhibitor-1 activity and VLDL triglyceride concentration, insulin levels and insulin sensitivity, Diabetologia, 36, 817, 10.1007/BF00400356 · DOI
  25. Schutz, 1993, Investigations into the haemorheological significance of postprandial and fasting hypertriglyceridaemia, Eur J Clin Invest, 23, 270, 10.1111/j.1365-2362.1993.tb00773.x · doi:10.1111/j.1365-2362.1993.tb00773.x
  26. Potter van Loon, 1993, The cardiovascular risk factor plasminogen activator inhibitor type 1 is related to insulin resistance, Metabolism, 42, 945, 10.1016/0026-0495(93)90005-9 · DOI · Paper page
  27. Mykkanen, 1994, Insulin sensitivity is not an independent determinant of plasma plasminogen activator inhibitor-1 activity, Arterioscler Thromb, 14, 1264, 10.1161/01.ATV.14.8.1264 · DOI
  28. Vague, 1995, Hypofibrinolysis and the insulin resistance syndrome, Int J Obes Relat Metab Disord, 19, S11
  29. Lindahl, 1996, Insulin resistance syndrome and fibrinolytic activity, Int J Epidemiol, 25, 291, 10.1093/ije/25.2.291 · DOI
  30. Juhan-Vague, 1997, PAI-1, obesity, insulin resistance and risk of cardiovascular events, Thromb Haemost, 78, 656, 10.1055/s-0038-1657607 · DOI · Paper page
  31. Colman, 1995, Weight loss reduces abdominal fat and improves insulin action in middle-aged and older men with impaired glucose tolerance, Metabolism, 44, 1502, 10.1016/0026-0495(95)90153-1 · DOI
  32. Ikeda, 1996, Improvement of insulin sensitivity contributes to blood pressure reduction after weight loss in hypertensive subjects with obesity, Hypertension, 27, 1180, 10.1161/01.HYP.27.5.1180 · DOI
  33. Bosello, 1997, The benefits of modest weight loss in type II diabetes, Int J Obes Relat Metab Disord, 21, S10
  34. Weinstock, 1998, Diet and exercise in the treatment of obesity, Arch Intern Med, 158, 2477, 10.1001/archinte.158.22.2477 · DOI
  35. Dengel, 1998, Improvements in blood pressure, glucose metabolism, and lipoprotein lipids after aerobic exercise plus weight loss in obese, hypertensive middle-aged men, Metabolism, 47, 1075, 10.1016/S0026-0495(98)90281-5 · DOI
  36. Markovic, 1998, The determinants of glycemic responses to diet restriction and weight loss in obesity and NIDDM, Diabetes Care, 21, 687, 10.2337/diacare.21.5.687 · DOI · Paper page
  37. Prigeon, 1995, Changes in insulin sensitivity, glucose effectiveness, and β-cell function in regularly exercising subjects, Metabolism, 44, 1259, 10.1016/0026-0495(95)90026-8 · DOI · Paper page
  38. Dengel, 1996, Distinct effects of aerobic exercise training and weight loss on glucose homeostasis in obese sedentary men, J Appl Physiol, 81, 318, 10.1152/jappl.1996.81.1.318 · DOI · Paper page
  39. Etgen, 1997, Exercise training reverses insulin resistance in muscle by enhanced recruitment of GLUT-4 to the cell surface, Am J Physiol, 272, E864
  40. Brown, 1997, Improvement of insulin sensitivity by short-term exercise training in hypertensive African American women, Hypertension, 30, 1549, 10.1161/01.HYP.30.6.1549 · DOI
  41. Bonen, 1998, Glucose tolerance is improved after low- and high-intensity exercise in middle-age men and women, Can J Appl Physiol, 23, 583, 10.1139/h98-033 · DOI
  42. Goodyear, 1998, Exercise, glucose transport, and insulin sensitivity, Annu Rev Med, 49, 235, 10.1146/annurev.med.49.1.235 · DOI · Paper page
  43. Mayer-Davis, 1998, Intensity and amount of physical activity in relation to insulin sensitivity, JAMA, 279, 669, 10.1001/jama.279.9.669 · DOI · Paper page
  44. Henry, 1997, Thiazolidinediones, Endocrinol Metab Clin North Am, 26, 553, 10.1016/S0889-8529(05)70267-X · DOI
  45. Gitlin, 1998, Two cases of severe clinical and histologic hepatotoxicity associated with troglitazone, Ann Intern Med, 129, 36, 10.7326/0003-4819-129-1-199807010-00008 · DOI · Paper page
  46. Vella, 1998, Fatal hepatotoxicity associated with troglitazone, Ann Intern Med, 129, 1080, 10.7326/0003-4819-129-12-199812150-00032 · DOI
  47. Manninen, 1989, Relation between baseline lipid and lipoprotein values and the incidence of coronary heart disease in the Helsinki Heart Study, Am J Cardiol, 63, 42H, 10.1016/0002-9149(89)90115-X · DOI
  48. Carlson, 1988, Reduction of mortality in the Stockholm ischaemic heart disease secondary prevention study to combined treatment with clofibrate and nicotinic acid, Acta Med Scand, 223, 405, 10.1111/j.0954-6820.1988.tb15891.x · DOI · Paper page
  49. Vega, 1990, Management of primary mixed hyperlipidemia with lovastatin, Arch Intern Med, 150, 1313, 10.1001/archinte.1990.00390180119022 · DOI

Cited by

See all 610

Metadata

Authors
Grundy, S. M.
Venue
The American Journal of Cardiology
Publisher
Elsevier BV
Published
1999-05
Volume
83
Issue
9
Pages
25-29
ISSN
0002-9149 (ISSN-L)
OpenAlex
W2060409824
Cited by
610
References
11
FWCI
14.26
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Hypertriglyceridemia, insulin resistance, and the metabolic syndrome. https://app.cochat.ai/papers/10.1016/s0002-9149(99)00211-8
The paper
Grundy, S. M. (1999). Hypertriglyceridemia, insulin resistance, and the metabolic syndrome. The American Journal of Cardiology. https://doi.org/10.1016/s0002-9149(99)00211-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.